Myelopeptide-2 (MP-2) is an endogenous regulatory peptide implicated in hematopoietic and immunomodulatory processes. Its sequence supports studies of receptor-mediated signaling in bone marrow–derived cells. Researchers employ it to explore structural features that control immune cell communication. The peptide aids mapping of myelopeptide-driven regulatory networks.
CAT No: B1603
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More